| ASSET | QUARTER | % RETURN |
|---|---|---|
Biogen (BIIB) | Q4 1995 | 147.62% |
NetApp (NTAP) | Q4 1995 | 95.73% |
Hologic (HOLX) | Q4 1995 | 78.26% |
Intuit (INTU) | Q4 1995 | 65.96% |
TJX Companies (TJX) | Q4 1995 | 60.49% |
Cadence Design Systems (CDNS) | Q4 1995 | 58.49% |
Gilead Sciences (GILD) | Q4 1995 | 45.48% |
Gartner (IT) | Q4 1995 | 43.98% |
Vertex Pharmaceuticals (VRTX) | Q4 1995 | 42.28% |
Humana (HUM) | Q4 1995 | 36.02% |
UnitedHealth (UNH) | Q4 1995 | 35.14% |
Telkom Indonesia (Persero) Tbk PT ADR Rep 100 B (TLK) | Q4 1995 | 32.89% |
Deere (DE) | Q4 1995 | 30.7% |
Universal Health Services (UHS) | Q4 1995 | 30.04% |
MasTec (MTZ) | Q4 1995 | 29.27% |
Renaissancere (RNR) | Q4 1995 | 28.98% |
Zebra Technologies (ZBRA) | Q4 1995 | 28.91% |
Fifth Third Bancorp (FITB) | Q4 1995 | 28.63% |
Erie Indemnity (ERIE) | Q4 1995 | 28.55% |
Nucor (NUE) | Q4 1995 | 27.82% |
Teva Pharma Industries Ltd ADR (TEVA) | Q4 1995 | 27.65% |
LIN TV (LIN) | Q4 1995 | 27.24% |
Eli Lilly and (LLY) | Q4 1995 | 26.94% |
CoreSite Realty (COR) | Q4 1995 | 26.93% |
IDEXX Laboratories (IDXX) | Q4 1995 | 26.21% |
Large-cap stocks are treated as having a market cap of $10B+.
